gms | German Medical Science

Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

09.09. - 12.09.2020, virtuell

A non-naïve and autoimmune prone IgD+ B cell pool is selectively supported by fibroblast like synoviocytes (FLS)

Meeting Abstract

Search Medline for

  • Dennis Bleck - Hiller Forschungszentrum Rheumatologie, Universitätsklinikum Düsseldorf, Rheumatologie, Düsseldorf
  • Matthias Schneider - Universitätsklinikum Düsseldorf, Poliklinik und Funktionsbereich für Rheumatologie, Düsseldorf
  • Georg Pongratz - Universitätsklinikum Düsseldorf Heinrich-Heine-Universität, Poliklinik und Funktionsbereich für Rheumatologie & Hiller Forchungszentrum für Rheumatologie, Düsseldorf

Deutsche Gesellschaft für Rheumatologie. Deutsche Gesellschaft für Orthopädische Rheumatologie. Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh). sine loco [digital], 09.-12.09.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocET.08

doi: 10.3205/20dgrh032, urn:nbn:de:0183-20dgrh0324

Published: September 9, 2020

© 2020 Bleck et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Introduction: IgD+ B cells show increased autoimmune potential compared to other subpopulations and serum IgD levels are increased in autoimmune disease [1], [2]. We investigated B cell-FLS co-cultures because FLS might be an essential factor in promoting the IgD+ B cell pool.

Methods: Peripheral total IgD+ B cells (DBC) and naïve B cells (NBC) were isolated from healthy donors by MACS and co-cultured with or w/o SFs in medium only or in the presence of IL-4. B cell subpopulations and survival were determined by FACS. Secreted IgG and IgD were measured by ELISA. Activation induced deaminase (AID) expression was demonstrated by in-situ PCR.

Results: After 3 days in culture, plasma cells (CD19-CD138+) were increased in NBC co-cultures as compared to DBC co-cultures (NBC: 0.045% of total B cells +/-0.03%; DBC: 0.01% of total B cells +/-0.01 %; p=0.03; IL-4: NBC: 0.14% of total B cells +/-0.08%; DBC: 0.015% of total B cells +/-0.015 %; p=0,03 ). Of these plasma cells, the IgG+ (switched) population was increased in NBC co-cultures as compared to DBC co-cultures in the presence of IL-4 (NBC: 48.9% of CD19-CD138+ B cells +/-40.42%; DBC: 0 % of CD19-CD138+ B cells +/- 0%; p=0.06). The memory B cell pool (CD19+CD27+) was expanded in DBC co-cultures compared to NBC co-cultures (DBC: 2.97% of total B cells +/-0.24%; NBC: 0.74% of total B cells +/-0.72%; p<0.001; IL-4: DBC: 6.24% of total B cells +/-0.21%; NBC: 0.8% of total B cells +/-0.38%; p < 0.001). Of these memory B cells, the IgD+ (non-switched) population was increased in the NBC co-cultures compared to the DBC co-cultures (naive: 82.7% of CD19+CD27+ B cells +/-11.5%; IgD+: 50.9% of CD19+CD27+ B cells +/-7.6%; p=0.001). IgG concentration in NBC co-culture supernatant was increased compared to DBC co-cultures (NBC: 153.5 ng/mL +/-8.8 ng/mL; DBC: 22.2 ng/mL +/-0.6 ng/mL; p = 0.02), while IgD concentration showed the opposite (NBC: non-detectable; DBC: 55 ng/mL +/-0.3 ng/mL; p<0.001). In-situ PCR proofed expression of AID in NBC co-culture.

Conclusion: It is not known why the autoimmune-prone IgD+ B cell pool is expanded in RA patients; in this regard, our data provide evidence, that FLS might be one pivotal factor for explaining this observation.

Disclosures: No conflicts of interest


References

1.
Koelsch K, Zheng NY, Zhang Q, Duty A, Helms C, Mathias MD, Jared M, Smith K, Capra JD, Wilson PC. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest. 2007;117(6):1558-65. DOI: 10.1172/JCI27628 External link
2.
Pope RM, Keightley R, McDuffy S. Circulating autoantibodies to IgD in rheumatic diseases. J Immunol. 1982 Apr;128(4): 1860-3.